Target intelligence / Profile preview

Pattern recognition receptors and immune effectors (PRRs)

Target
PRRs
Molecular classification
Receptor, Cytokine, Chemokine, Enzyme, Complement protein
01

Overview

Pattern recognition receptors (PRRs) and immune effectors represent the fundamental machinery of the innate immune system. PRRs, including Toll-like receptors (TLRs), NOD-like receptors (NLRs), and RIG-I-like receptors (RLRs), are specialized proteins that identify pathogen-associated molecular patterns (PAMPs) and damage-associated molecular patterns (DAMPs) [1][2]. Once these receptors are engaged, they initiate complex intracellular signaling pathways that culminate in the recruitment and activation of immune effectors, such as cytokines, chemokines, and the complement system [2]. This coordinated response is essential for the immediate defense against pathogens and the subsequent activation of adaptive immunity. However, aberrant PRR signaling or effector production is a hallmark of various pathologies, including sepsis, chronic inflammatory diseases, and cancer [3]. Therapeutic strategies often target specific members of this group, using agonists to boost immunity in oncology or vaccine development, and antagonists to dampen pathological inflammation in autoimmune conditions [3].

Other names
Innate immune receptorsPathogen recognition receptorsPAMP receptorsDAMP receptorsInnate immune system components
02

Mechanism of action

Modulation of innate immune signaling through the activation or inhibition of specific pattern recognition receptors or their downstream signaling effectors to regulate inflammatory and adaptive immune responses.

03

Biological functions

Immune responseInflammationSignal transductionApoptosisPathogen recognition
04

Disease associations

InfectionInflammationAutoimmune diseaseCancerNeurodegenerative disease
05

Safety considerations

Cytokine release syndromeIncreased susceptibility to infectionAutoimmunitySystemic inflammatory response
06

Interacting drugs

Imiquimod

5 more in the full profile.

07

Biomarkers

C-reactive protein (CRP)Interleukin-6 (IL-6)Tumor necrosis factor-alpha (TNF-alpha)Procalcitonin

Beyond the preview

Go deeper on Pattern recognition receptors and immune effectors (PRRs).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Pattern recognition receptors and immune effectors (PRRs).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call